Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Noble

Showing results (531-540 of 568) with videos related to

Pageof 57
Sort By:
JAMA Neurology|January 27, 2015
Factors associated with the onset and persistence of post-lumbar puncture headacheAndrés E Monserrate, Davis C Ryman, Shengmei Ma, et al.
JAMA Network Open|December 12, 2019
Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer DiseaseJorge J Llibre-Guerra, Yan Li, Suzanne E Schindler, et al.
The Journal of Antimicrobial Chemotherapy|November 26, 2010
Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporinsM E A de Kraker, M Wolkewitz, P G Davey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 11, 2026
Integrating real-world data with gold-standard longitudinal clinical and genomic data to advance precision medicine for the Alzheimer's Disease Research Center Program and beyond: a proof-of-concept data platformSarah Biber, Jessica E Culhane, Maria G Prado, et al.
Journal of Medicinal Chemistry|February 15, 2011
Isoindolinone inhibitors of the murine double minute 2 (MDM2)-p53 protein-protein interaction: structure-activity studies leading to improved potencyIan R Hardcastle, Junfeng Liu, Eric Valeur, et al.
British Journal of Cancer|July 17, 2020
The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancerSian M Noble, Kirsty Garfield, J Athene Lane, et al.
The Journal of Prevention of Alzheimer'S Disease|March 21, 2025
Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's diseaseDavid M Cash, Katy E Morgan, Antoinette O'Connor, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 9, 2019
Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's diseaseSuzanne E Schindler, Yan Li, Kaitlin W Todd, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's diseaseDavid M Cash, Katy E Morgan, Antoinette O'Connor, et al.
Journal of Medicinal Chemistry|April 25, 2022
Parallel Optimization of Potency and Pharmacokinetics Leading to the Discovery of a Pyrrole Carboxamide ERK5 Kinase Domain InhibitorDuncan C Miller, Tristan Reuillon, Lauren Molyneux, et al.
Pageof 57

Showing results (531-540 of 568) with videos related to

Sort By:
Pageof 57
JAMA Neurology|January 27, 2015
Factors associated with the onset and persistence of post-lumbar puncture headacheAndrés E Monserrate, Davis C Ryman, Shengmei Ma, et al.
JAMA Network Open|December 12, 2019
Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer DiseaseJorge J Llibre-Guerra, Yan Li, Suzanne E Schindler, et al.
The Journal of Antimicrobial Chemotherapy|November 26, 2010
Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporinsM E A de Kraker, M Wolkewitz, P G Davey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 11, 2026
Integrating real-world data with gold-standard longitudinal clinical and genomic data to advance precision medicine for the Alzheimer's Disease Research Center Program and beyond: a proof-of-concept data platformSarah Biber, Jessica E Culhane, Maria G Prado, et al.
Journal of Medicinal Chemistry|February 15, 2011
Isoindolinone inhibitors of the murine double minute 2 (MDM2)-p53 protein-protein interaction: structure-activity studies leading to improved potencyIan R Hardcastle, Junfeng Liu, Eric Valeur, et al.
British Journal of Cancer|July 17, 2020
The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancerSian M Noble, Kirsty Garfield, J Athene Lane, et al.
The Journal of Prevention of Alzheimer'S Disease|March 21, 2025
Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's diseaseDavid M Cash, Katy E Morgan, Antoinette O'Connor, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 9, 2019
Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's diseaseSuzanne E Schindler, Yan Li, Kaitlin W Todd, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's diseaseDavid M Cash, Katy E Morgan, Antoinette O'Connor, et al.
Journal of Medicinal Chemistry|April 25, 2022
Parallel Optimization of Potency and Pharmacokinetics Leading to the Discovery of a Pyrrole Carboxamide ERK5 Kinase Domain InhibitorDuncan C Miller, Tristan Reuillon, Lauren Molyneux, et al.
Pageof 57